Daniel L. Flynn, is Executive Vice President, Chief Scientific Officer and Founder of Deciphera Pharmaceuticals. Dr. Flynn founded Deciphera in 2003 and has more than 38 years of experience within the pharmaceutical and biotechnology industry. Before founding Deciphera, Dr. Flynn held senior roles with various biotechnology and pharmaceuticals companies, including Senior Director of Chemistry with Millennium Pharmaceuticals, Director, Medicinal Chemistry at Amgen Inc., and Director of Medicinal Chemistry, Combinatorial Chemistry and Research Fellow at Monsanto Company, G.D. Searle Unit. Dr. Flynn is currently Adjunct Professor of Medicinal Chemistry at the University of Kansas-Lawrence and has served as the National Chair for the Division of Medicinal Chemistry of the American Chemical Society. Dr. Flynn received both his B.S. in pharmacy and Ph.D. in medicinal chemistry from the University of Kansas, and he completed post-doctorate training in synthetic organic chemistry at Indiana University.